Global demand for China's pharmaceuticals is strong.

An increasing number of Chinese pharmaceutical companies, in particular privately-owned firms in coastal areas, are eyeing the international market.

This is the first time the growth rate surpassed the country's overall export growth.

Chinese pharmaceutical companies are seeing more anti-dumping or anti-subsidy cases. The conflicts are spreading to some major exports.

Domestic companies are working to counteract the on-going dumping claims. They understand that they might totally lose the target market if they do not respond.

Mothers are generally reluctant to come. When a mother turns up, she is often a single mother who wants to get evidence to find out the biological father of the child so she can demand compensation.